Fresh Tracks Therapeutics Inc Asset Turnover Ratio (FRTX), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Fresh Tracks Therapeutics Inc   (FRTX)
 

Fresh Tracks Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Dec 31 2023, Fresh Tracks Therapeutics Inc has not recorded any assets.
Visit Fresh Tracks Therapeutics Inc Balance sheet

Within sector Fresh Tracks Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition



FRTX Asset Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Asset Change 12.8 % -9.62 % -46.82 % -42.31 % -65.37 %
Y / Y Revenue Change - 1534.57 % -98.77 % -90.22 % 1871.15 %
Asset Turnover Ratio (TTM) - 0.89 0.22 0.5 0.43
FRTX's Total Ranking # # # # #
Seq. Asset Change -11.27 % 32.67 % -17.76 % 16.51 % -28.91 %
Seq. Revenue Change - 14888.68 % 488.89 % -99.56 % 321.81 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Bespoke Extracts Inc  1.88 $ 0.786  Millions$ 0.417  Millions
Integrated Biopharma Inc  1.87 $ 48.833  Millions$ 26.168  Millions
Nature s Sunshine Products inc   1.85 $ 445.127  Millions$ 240.106  Millions
Neptune Wellness Solutions Inc   1.83 $ 39.115  Millions$ 21.405  Millions
Sunlink Health Systems Inc   1.82 $ 40.052  Millions$ 22.052  Millions
Rockwell Medical inc   1.81 $ 82.927  Millions$ 45.822  Millions
Privia Health Group Inc   1.74 $ 1,657.737  Millions$ 951.287  Millions
Zeo Scientifix Inc   1.69 $ 4.642  Millions$ 2.751  Millions
Mimedx Group Inc   1.66 $ 320.687  Millions$ 193.151  Millions
Kewaunee Scientific Corporation  1.61 $ 198.397  Millions$ 122.932  Millions
Encision Inc   1.61 $ 6.867  Millions$ 4.256  Millions
Agile Therapeutics Inc  1.57 $ 18.615  Millions$ 11.853  Millions
Champions Oncology Inc   1.55 $ 49.224  Millions$ 31.706  Millions
Progyny Inc   1.55 $ 1,087.799  Millions$ 703.598  Millions
Vycor Medical Inc   1.54 $ 1.459  Millions$ 0.947  Millions
Cv Sciences Inc   1.50 $ 15.085  Millions$ 10.048  Millions
Chemed Corporation  1.47 $ 2,264.417  Millions$ 1,541.635  Millions
Docgo Inc   1.46 $ 624.289  Millions$ 427.017  Millions
The Oncology Institute Inc   1.45 $ 324.239  Millions$ 223.046  Millions
P3 Health Partners Inc   1.43 $ 1,266.375  Millions$ 883.560  Millions
Psychemedics Corporation  1.41 $ 21.413  Millions$ 15.181  Millions
Iridex Corp  1.41 $ 51.807  Millions$ 36.826  Millions
International Stem Cell Corporation  1.41 $ 7.789  Millions$ 5.540  Millions
Procyon Corporation  1.36 $ 4.700  Millions$ 3.449  Millions
Zynex inc   1.34 $ 184.322  Millions$ 137.990  Millions
Option Care Health Inc   1.33 $ 4,302.223  Millions$ 3,227.988  Millions
Myomo Inc   1.31 $ 19.182  Millions$ 14.667  Millions
Innovage Holding Corp   1.30 $ 720.796  Millions$ 554.155  Millions
Henry Schein Inc   1.30 $ 12,339.000  Millions$ 9,525.250  Millions
Cidara Therapeutics Inc   1.28 $ 90.012  Millions$ 70.055  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.